Landscape Capital Management’s Context Therapeutics CNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding CNTX
Landscape Capital Management's CNTX Position: Q3 2026 in Review
Landscape Capital Management opened a new position in Context Therapeutics (CNTX) in Q3 2026: 241,312 shares worth $72.5K. The stake represents 0.01% of the portfolio and ranks #574 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in CNTX as recently as Q1 2025.
Landscape Capital Management first reported a position in CNTX in Q4 2024 and has held it in 3 quarters since. The position peaked at $94.5K in Q4 2024. 87 funds tracked by Wall St. Rank hold CNTX as of Q3 2026.
- Landscape Capital Management held 241,312 shares of Context Therapeutics worth $72.5K as of Q3 2026.
- Context Therapeutics was a new Landscape Capital Management position in Q3 2026.
- Context Therapeutics made up 0.01% of Landscape Capital Management's portfolio in Q3 2026, its #574 holding.
- Landscape Capital Management first reported a position in Context Therapeutics in Q4 2024 and has held it in 3 quarters since.
- Landscape Capital Management's Context Therapeutics position peaked at $94.5K in Q4 2024.
- 87 funds tracked by Wall St. Rank held Context Therapeutics as of Q3 2026.
Based on Landscape Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.